Longview Acquisition II priced its IPO of 60 million units at $10 each, an upsize of 20 percent from the 50 million units it initially registered.
Each units consists of one share of common stock and one-fifth of a warrant; whole warrants exercisable at $11.50.
Units begin trading today on the NYSE under LGV.U.
The SPAC’s acquisition focus is on healthcare, but Longview will also consider industrials, consumer, media, technology and technology services companies. Read more.
